Moreover, defining exact mechanisms whereby BIRC2-3 contribute to oncogenesis in FA cells will be crucial for a deeper understanding of FA-HNSCC biology and treatment. This evidence concerns the gene BIRC2 and head and neck squamous cell carcinoma.